CVS

SEC source: 0001127602-21-012769 · form4.xml · nonDerivative · entry 2

Lynch Karen S · CIK 0001333760 · EVP and President, Aetna

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,091

F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

SEC source: 0001127602-21-012779 · form4.xml · nonDerivative · entry 3

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 632,946.9407

F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.

SEC source: 0001127602-21-012779 · form4.xml · nonDerivative · entry 2

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 622,517.9407

F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

SEC source: 0001127602-21-012782 · form4.xml · derivative · entry 2

Montgomery Neela · CIK 0001716048 · EVP and Pres., Pharmacy/Retail

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 86,386

Underlying: Common Stock · 86,386 shares

Expires 2031-04-01

F1 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022.

SEC source: 0001127602-21-012790 · form4.xml · derivative · entry 7

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,495

Underlying: Common Stock · 155,495 shares

Expires 2031-04-01

F4 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022.

SEC source: 0001127602-21-012790 · form4.xml · nonDerivative · entry 3

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,373

F3 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.

SEC source: 0001127602-21-012790 · form4.xml · nonDerivative · entry 2

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,953

F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

SEC source: 0001127602-21-012812 · form4.xml · derivative · entry 7

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 172,772

Underlying: Common Stock · 172,772 shares

Expires 2031-04-01

F3 · derivative.exercise_date: Option becomes exercisable in four equal installments, commencing 4/1/2022.

SEC source: 0001127602-21-012812 · form4.xml · nonDerivative · entry 2

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,760.717

F2 · shares: Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.

SEC source: 0001127602-21-012633 · form4.xml · derivative · entry 4

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,350 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.

SEC source: 0001127602-21-012633 · form4.xml · nonDerivative · entry 2

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,244.2554

F1 · kind: All sales were effective pursuant to a Rule 10b5-1 plan.

SEC source: 0001127602-21-012633 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,594.2554

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-012328 · form4.xml · derivative · entry 6

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 62,943 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-012328 · form4.xml · nonDerivative · entry 2

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sale prices ranging between $75.51 and $76.68 per share.

SEC source: 0001127602-21-012328 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,943

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-012256 · form4.xml · derivative · entry 7

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 271,347 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-012256 · form4.xml · nonDerivative · entry 2

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 524,025.9407

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 Plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the Reporting Person retaining all remaining shares.

F2 · price: Represents weighted average sale prices for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.73 per share.

SEC source: 0001127602-21-012256 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 794,675.9407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-012257 · form4.xml · derivative · entry 7

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 73,433 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-012257 · form4.xml · nonDerivative · entry 2

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 663.717

F1 · kind: All sales were effected pursuant to Rule 10b5-1 plan.

SEC source: 0001127602-21-012257 · form4.xml · nonDerivative · entry 1

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 74,096.717

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-011860 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 18,226.0221

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.00 and $74.58 per share.

SEC source: 0001127602-21-011098 · form4.xml · derivative · entry 4

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 18,882 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-011098 · form4.xml · nonDerivative · entry 2

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,082.0445

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

F2 · price: Represents weighted average sale price for this group of sales, which occurred on the same trading day. Multiple sales were executed, with sales prices ranging between $74.49 and $75.00 per share.

SEC source: 0001127602-21-011098 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,964.0445

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-008848 · form4.xml · nonDerivative · entry 1

Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,073.1519

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

SEC source: 0001127602-21-008769 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,244.2554

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

SEC source: 0001127602-21-008773 · form4.xml · nonDerivative · entry 1

Flum Joshua Matthew · CIK 0001412223 · EVP, ENT STRATEGY & DIGITAL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,656.958

F1 · shares: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.

SEC source: 0001127602-21-008759 · form4.xml · nonDerivative · entry 1

Havanec Laurie P. · CIK 0001807757 · EVP and Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,033

F1 · shares: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 2/26/2022.

SEC source: 0001127602-21-006284 · form4.xml · nonDerivative · entry 1

LUDWIG EDWARD J · CIK 0001221783 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,334

SEC source: 0001127602-21-012689 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · Former EVP & Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,103

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012693 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,074.059

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012695 · form4.xml · nonDerivative · entry 1

Boratto Eva C · CIK 0001580827 · EVP & CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 159,582.0445

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012713 · form4.xml · nonDerivative · entry 1

Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,930.2554

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012728 · form4.xml · nonDerivative · entry 1

Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,079.1519

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012762 · form4.xml · nonDerivative · entry 1

Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 104,121.6756

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012769 · form4.xml · nonDerivative · entry 1

Lynch Karen S · CIK 0001333760 · EVP and President, Aetna

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,302

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012779 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 703,520.9407

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012790 · form4.xml · nonDerivative · entry 1

Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,048

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-012812 · form4.xml · nonDerivative · entry 1

Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,474.717

F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.

SEC source: 0001127602-21-002274 · form4.xml · derivative · entry 7

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,347

Underlying: Common Stock · 64,350 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-002274 · form4.xml · nonDerivative · entry 2

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 523,328.9407

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.

SEC source: 0001127602-21-002274 · form4.xml · nonDerivative · entry 1

MERLO LARRY J · CIK 0001194413 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 586,221.9407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-001603 · form4.xml · derivative · entry 6

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,177 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-001603 · form4.xml · nonDerivative · entry 2

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,588

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

SEC source: 0001127602-21-001603 · form4.xml · nonDerivative · entry 1

Bisaccia Lisa · CIK 0001479663 · EVP and Chief HR Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,765

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-001521 · form4.xml · derivative · entry 4

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 54,550 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2015.

SEC source: 0001127602-21-001521 · form4.xml · nonDerivative · entry 2

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,558.059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-21-001521 · form4.xml · nonDerivative · entry 1

Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,008.059

F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan.

SEC source: 0001127602-21-001522 · form4.xml · derivative · entry 8

Lotvin Alan · CIK 0001472795 · EVP and President-CVS Caremark

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,736 shares

Expires 2021-04-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Remaining options became exercisable in four equal annual installments beginning on 4/1/2015.